Human studies demonstrate that patients receiving TNF-?? inhibitors for chronic inflammatory diseases such as rheumatoid arthritis and Crohnrs disease can develop active TB due to reactivation of latent M. tb infection [12, 22, 28???30], further highlighting the significance of TNF-?? in protection against M. tb infection.